Glycated albumin for glycemic control of diabetic patients on hemodialysis

Article Sidebar

PDF
Published: 2014-04-19
DOI: https://doi.org/10.18051/UnivMed.2014.v33.1-2
Keywords:
Glycated albumin, diabetic, hemodialysis

Main Article Content

Alvina Alvina
Medical Faculty, Trisakti University

Abstract

Regular assessment of glycemic control in diabetic patients is very important, because it reduces the incidence of complications and determines prognosis and quality of life of the patients.(1) Uncontrolled and advanced diabetes may lead to complications, such as kidney disease, heart attacks, and stroke, which are on the increase worldwide. Patients with diabetic nephropathy account for almost 50% of dialysis patients in the US, while cardiovascular disease is the main cause of death of patients with complicated diabetes.(2)

Article Details

Issue

Vol. 33 No. 1 (2014)

Section

Review Article

The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.

Author Biography

Alvina Alvina, Medical Faculty, Trisakti University

Department of Pathology Clinic

How to Cite

Glycated albumin for glycemic control of diabetic patients on hemodialysis. (2014). Universa Medicina, 33(1), 1-2. https://doi.org/10.18051/UnivMed.2014.v33.1-2

References

Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, et al. Glycated albumin is a better glycemic

indicator than glycated hemoglobin values in hemodialysis patients with diabetes:effect of anemia and

erythropoietin injection. J Am Soc Nephrol 2007;18: 896-903.

Peacock TP, Shihabi ZK, Bleyer AJ, Dolbare EL, Byers JR, Knovich MA, et al. Comparison of glycated

albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis. Kidney Int 2008;73:1062-8.

Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J

;57:751-62.

Freedman BI, Shihabi ZK, Andries L, Cardona CY, Peacock TP, Byers JR, et al. Relationship between assays

of glycemia in diabetic subjects with advanced chronic kidney disease. Am J Nephrol 2010;31:375-9.

Takahashi S, Uchino H, Shimizu T, Kanazawa A, Tamura Y, Sakai K, et al. Comparison of glycated albumin

(GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of

short-term changes in glycemic control. Endocr J 2007;54:139-44.

Fukuoka K, Nakao K, Morimoto H, Nakao A, Takatori Y, Arimoto K, et al. Glycated albumin level predict long

term survival in diabetic patients undergoing haemodialysis. Nephrology 2008;13:278-83.